Tag: MOR106

Novartis to in-license atopic dermatitis drug MOR106 from MorphoSys, Galapagos

pharmanewsdaily- July 21, 2018

Novartis has agreed to acquire the exclusive global development and marketing rights of atopic dermatitis drug MOR106 from MorphoSys and Galapagos in a deal that ... Read More